The impact of postrandomization crossover of therapy in acute coronary syndromes care.
Circulation: Cardiovascular Quality and Outcomes.
Times cited: 4
Prediction of one-year survival in high-risk patients with acute coronary syndromes: Results from the SYNERGY trial.
Journal of General Internal Medicine.
Times cited: 36
High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: Outcomes at 6 months and 1 year in the SYNERGY trial.
JAMA - Journal of the American Medical Association.
Times cited: 60